CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Ten Year Follow-up in FSHD: the FOCUS 3 Study

This update covers the FOCUS 3 study for facioscapulohumeral muscular dystrophy and indicates that recruitment is ongoing for its ten-year follow-up.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Radboud University Medical Center | Conditions: FSHD - Facioscapulohumeral Muscular Dystrophy | Status: RECRUITING